{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:13:04Z","timestamp":1769022784031,"version":"3.49.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012415","name":"Biomedical Research Council","doi-asserted-by":"publisher","award":["H20\/04\/g1\/005"],"award-info":[{"award-number":["H20\/04\/g1\/005"]}],"id":[{"id":"10.13039\/501100012415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Government of Singapore Ministry of Health","doi-asserted-by":"publisher","award":["PREPARE-OC-VT-2022-001"],"award-info":[{"award-number":["PREPARE-OC-VT-2022-001"]}],"id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.isci.2025.112687","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T12:00:15Z","timestamp":1747396815000},"page":"112687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A combinatorial and computational Tandem approach towards a universal therapeutics against ACE2-mediated coronavirus infections"],"prefix":"10.1016","volume":"28","author":[{"given":"Chia Yin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9233-3002","authenticated-orcid":false,"given":"Ching-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Louis","family":"De Falco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabiatul Adawiyah","family":"Minhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Traversier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti Nazihah","family":"Mohd Salleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve Zi Xian","family":"Ngoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew Zirui","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Rosa-Calatrava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Pizzorno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland G.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-2996","authenticated-orcid":false,"given":"Cheng-I","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112687_bib1","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112687_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112687_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.abf9302","article-title":"Prospective mapping of viral mutations that escape antibodies used to treat COVID-19","volume":"371","author":"Starr","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112687_bib4","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.cell.2021.04.033","article-title":"Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia","volume":"184","author":"Asarnow","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112687_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28875","article-title":"Deconstructing SARS-CoV-2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD","volume":"95","author":"Tragni","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.isci.2025.112687_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-020-00369-3","article-title":"SARS-CoV-2 spike protein: flexibility as a new target for fighting infection","volume":"5","author":"Pierri","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.112687_bib7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00018-020-03580-1","article-title":"Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies","volume":"78","author":"Mercurio","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2025.112687_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2022.1009451","article-title":"SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility","volume":"4","author":"Val\u00e9rio","year":"2022","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.isci.2025.112687_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112687_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112687_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112687_bib12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1080\/22221751.2020.1787797","article-title":"Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion","volume":"9","author":"Zheng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.isci.2025.112687_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01283-20","article-title":"SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig","volume":"94","author":"Li","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2025.112687_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.aivir.2019.08.002","article-title":"Structural insights into coronavirus entry","volume":"105","author":"Tortorici","year":"2019","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.isci.2025.112687_bib15","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1038\/s41467-021-24013-y","article-title":"Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2","volume":"12","author":"Higuchi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112687_bib16","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112687_bib17","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112687_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.588618","article-title":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives","volume":"7","author":"Saponaro","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2025.112687_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2162","article-title":"The emerging role of ACE2 in physiology and disease","volume":"212","author":"Hamming","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2025.112687_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2213","article-title":"Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients","volume":"31","author":"Rahman","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.isci.2025.112687_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.tig.2020.08.003","article-title":"Host Polymorphisms May Impact SARS-CoV-2 Infectivity","volume":"36","author":"Brest","year":"2020","journal-title":"Trends Genet."},{"key":"10.1016\/j.isci.2025.112687_bib22","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112687_bib23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41401-020-0430-6","article-title":"Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication","volume":"41","author":"Pang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2025.112687_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112687_bib25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.tips.2022.06.011","article-title":"Engineering ACE2 decoy receptors to combat viral escapability","volume":"43","author":"Arimori","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.isci.2025.112687_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252799","article-title":"Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients","volume":"16","author":"Kragstrup","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112687_bib27","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1093\/eurheartj\/ehaa697","article-title":"Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation","volume":"41","author":"Wallentin","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2025.112687_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112687_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101580","article-title":"Multivalent ACE2 engineering-A promising pathway for advanced coronavirus nanomedicine development","volume":"46","author":"Obeng","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.isci.2025.112687_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41422-020-00438-w","article-title":"Engineered trimeric ACE2 binds viral spike protein and locks it in \"Three-up\" conformation to potently inhibit SARS-CoV-2 infection","volume":"31","author":"Guo","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2025.112687_bib31","doi-asserted-by":"crossref","first-page":"28046","DOI":"10.1073\/pnas.2016093117","article-title":"Engineered ACE2 receptor traps potently neutralize SARS-CoV-2","volume":"117","author":"Glasgow","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112687_bib32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.abc0870","article-title":"Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2","volume":"369","author":"Chan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112687_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf1738","article-title":"An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants","volume":"7","author":"Chan","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2025.112687_bib34","article-title":"An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants","volume":"11","author":"Tanaka","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112687_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105193","article-title":"Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern","volume":"25","author":"Cohen-Dvashi","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.isci.2025.112687_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009544","article-title":"Intranasal gene therapy to prevent infection by SARS-CoV-2 variants","volume":"17","author":"Sims","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.112687_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2020.110425","article-title":"Design of an engineered ACE2 as a novel therapeutics against COVID-19","volume":"505","author":"Payandeh","year":"2020","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.isci.2025.112687_bib38","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1021\/acs.jcim.1c00783","article-title":"Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV-2 Spike (S) Protein with Tight Nanomolar Affinity","volume":"61","author":"Havranek","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.isci.2025.112687_bib39","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41598-023-27636-x","article-title":"Optimizing variant-specific therapeutic SARS-CoV-2 decoys using deep-learning-guided molecular dynamics simulations","volume":"13","author":"K\u00f6chl","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112687_bib40","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/j.1742-4658.2005.04756.x","article-title":"Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis","volume":"272","author":"Guy","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.isci.2025.112687_bib41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41467-022-28528-w","article-title":"Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112687_bib42","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1038\/s41467-022-31276-6","article-title":"Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses","volume":"13","author":"Xu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112687_bib43","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1128\/JVI.00631-14","article-title":"Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China","volume":"88","author":"He","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2025.112687_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006698","article-title":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus","volume":"13","author":"Hu","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.112687_bib45","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.112687_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108528","article-title":"An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2","volume":"33","author":"Tada","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112687_bib47","article-title":"Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia","volume":"1","author":"Pizzorno","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.112687_bib48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41586-020-2558-4","article-title":"Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates","volume":"585","author":"Maisonnasse","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112687_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2025.112687_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112687_bib51","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112687_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn7737","article-title":"An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo","volume":"14","author":"Ikemura","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.112687_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi2623","article-title":"An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models","volume":"15","author":"Urano","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.112687_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271359","article-title":"High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses","volume":"17","author":"Sims","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112687_bib56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s42003-023-04860-9","article-title":"A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo","volume":"6","author":"Havranek","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2025.112687_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpj.2021.11.664","article-title":"Computationally engineered ACE2 decoy binds with nanomolar affinity with the SARS-CoV-2 spike protein","volume":"121","author":"Islam","year":"2022","journal-title":"Biophys. J."},{"key":"10.1016\/j.isci.2025.112687_bib57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41589-021-00965-6","article-title":"Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants","volume":"18","author":"Zhang","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2025.112687_bib58","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216109","article-title":"An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2","volume":"14","author":"Zhang","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2025.112687_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009501","article-title":"Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2","volume":"17","author":"Mou","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.112687_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41392-021-00756-4","article-title":"S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis","volume":"6","author":"Ye","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.112687_bib61","article-title":"Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities","volume":"8","author":"Chen","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2025.112687_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.691715","article-title":"Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern","volume":"12","author":"Deshpande","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112687_bib63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13167-021-00267-w","article-title":"Modeling SARS-CoV-2 spike\/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context","volume":"13","author":"Tragni","year":"2022","journal-title":"EPMA J."},{"key":"10.1016\/j.isci.2025.112687_bib64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41597-020-00652-6","article-title":"Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design","volume":"7","author":"Sorokina","year":"2020","journal-title":"Sci. Data"},{"key":"10.1016\/j.isci.2025.112687_bib65","article-title":"Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity","author":"Irene Lui","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2025.112687_bib66","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1038\/s41467-023-40933-3","article-title":"An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112687_bib73","doi-asserted-by":"crossref","first-page":"W382","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: an online force field","volume":"33","author":"Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.112687_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102415","article-title":"Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody","volume":"9","author":"Ng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112687_bib68","doi-asserted-by":"crossref","first-page":"W368","DOI":"10.1093\/nar\/gki464","article-title":"H++: a server for estimating pKas and adding missing hydrogens to macromolecules","volume":"33","author":"Gordon","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.112687_bib69","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.isci.2025.112687_bib70","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.112687_bib71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-2836(02)00442-4","article-title":"Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations","volume":"320","author":"Guerois","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.isci.2025.112687_bib72","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1093\/bioinformatics\/btz184","article-title":"FoldX 5.0: working with RNA, small molecules and a new graphical interface","volume":"35","author":"Delgado","year":"2019","journal-title":"Bioinformatics"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225009484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225009484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:55:24Z","timestamp":1768964124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225009484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589004225009484"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112687","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A combinatorial and computational Tandem approach towards a universal therapeutics against ACE2-mediated coronavirus infections","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112687"}}